These changes are thought to affect markers of haematopoietic stem cells, such as CD41 and CD61, and the differentiation of megakaryocytes, ultimately decreasing the function and quantity of platelets and leading to the onset of ITP [3]. The gene discussed is ITGA2B; the disease is autoimmune thrombocytopenic purpura.